Advanced Biomed Stock Inches Up Before Nasdaq Opens As AI Pivot Faces Its First Real Tests
Advanced Biomed Inc. shares rose to $4.4135 premarket Wednesday, up 8.5 cents. The company recently acquired Acellent Technologies for $1.08 million and shifted focus from life sciences to artificial intelligence. Xiaomin Chen replaced Yi Lu as CEO and chairman in April. The firm reported a $488,942 net loss last quarter.